Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO METHAZIDE 25 | 25MG 250MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18936 |
| ACCURETIC | 12.5MG 10MG | TABLET | Actual shortage | 2022-03-01 | 2022-03-02 | 155797 |
| ACCURETIC | 12.5MG 20MG | TABLET | Actual shortage | 2022-03-01 | 2022-03-02 | 155800 |
| ACCURETIC | 20MG 25MG | TABLET | Resolved | 2020-11-22 | 2020-12-16 | 128708 |
| ACCURETIC | 25MG 20MG | TABLET | Actual shortage | 2022-03-01 | 2022-03-02 | 155803 |
| TEVETEN PLUS | 12.5MG 600MG | TABLET | Resolved | 2018-11-08 | 2019-01-16 | 66450 |
| TEVETEN PLUS | 12.5MG 600MG | TABLET | Resolved | 2019-01-18 | 2019-04-04 | 72948 |
| TEVETEN PLUS | 12.5MG 600MG | TABLET | Resolved | 2019-11-28 | 2020-07-16 | 99916 |
| TEVETEN PLUS | 600MG 12.5MG | TABLET | Avoided shortage | 2020-07-16 | 2020-08-04 | 120414 |
| TEVETEN PLUS | 600MG 12.5MG | TABLET | Avoided shortage | 2020-09-22 | 2020-09-29 | 124719 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
| ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
| ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
| RAMIPRIL-HCTZ | Discontinued | 2018-12-21 | 2018-12-22 | 70392 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 |